Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
CC transcript
CORE LABORATORIES N V (CLB) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/26/2023 8-K Quarterly results
02/03/2023 8-K Quarterly results
02/01/2023 8-K Quarterly results
01/17/2023 8-K Quarterly results
11/04/2022 8-K Quarterly results
10/26/2022 8-K Quarterly results
07/27/2022 8-K Quarterly results
Docs: "CORE LABORATORIES N.V. & SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended % Variance June 30, 2022 June 30, 2021 vs. Q1-22 vs. Q2-21 REVENUE $120,898 $115,300 $118,745 4.9% 1.8% OPERATING EXPENSES: Costs of services and sales 97,957 96,952 93,841 1.0% 4.4% General and administrative expense 6,847 12,545 9,670 % % Depreciation and amortization 4,360 4,557 4,751 % % Other expense, net 82 1,637 % NM Total operating expenses 109,246 115,691 105,945 % 3.1% OPERATING INCOME 11,652 12,800 NM % Interest expense 2,707 2,644 2,530 2.4% 7.0% Income from continuing operations before income tax expense 8,945 10,270 NM % Income tax expense 1,789 2,053 NM % Income from continuing operations 7,156 8,217 NM % Net income 7,156 8,217 NM % Net income attributable to non-control..."
07/26/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
04/27/2022 8-K Quarterly results
Docs: "CORE LABORATORIES N.V. & SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended % Variance vs. Q4-21 vs. Q1-21 REVENUE $ 115,300 $ 125,139 $ 108,383 % 6.4% OPERATING EXPENSES: Costs of services and sales 96,952 96,987 84,150 —% 15.2% General and administrative expense 12,545 10,927 8,461 14.8% 48.3% Depreciation and amortization 4,557 4,398 4,871 3.6% % Other expense, net 1,637 NM NM Total operating expenses 115,691 110,939 96,761 4.3% 19.6% OPERATING INCOME 14,200 11,622 NM NM Interest expense 2,644 2,590 1,363 2.1% 94.0% Income from continuing operations before income tax expense 11,610 10,259 NM NM Income tax expense 8,823 2,052 NM NM Income from continuing operations 2,787 8,207 NM NM Net income 2,787 8,207 NM NM Net income attributable to non-controlling ..."
03/16/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CORE LAB ANNOUNCES: • REVISED Q1 2022 GUIDANCE • CONSTRUCTIVE VIEW ON 2022 COMPANY OUTLOOK • LAUNCH OF INDUSTRY CARBON CAPTURE AND SEQUESTRATION CONSORTIUM • FIRST QUARTER 2022 EARNINGS WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON 28 APRIL 2022 AMSTERDAM - Core Laboratories N.V. is announcing revised guidance from continuing operations for the first quarter of 2022, as well as commencement of a joint-industry consortium project focused on carbon capture and sequestration . REVISED Q1 2022 GUIDANCE There have been two significant events impacting Core’s financial results since the Company provided its initial guidance for the first quarter of 2022 on 2 February 2022: the outbreak of the Omicron variant of COVID-19 was much more significant than initially predict..."
02/02/2022 8-K Quarterly results
10/27/2021 8-K Quarterly results
Docs: "CORE LABORATORIES N.V. & SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended % Variance vs. Q2-21 vs. Q3-20 REVENUE $ 117,985 $ 118,745 $ 105,382 % 12.0% OPERATING EXPENSES: Costs of services and sales 92,918 93,841 81,038 % 14.7% General and administrative expense 15,115 9,670 8,937 56.3% 69.1% Depreciation and amortization 4,496 4,751 5,164 % % Other expense, net NM NM Total operating expenses 111,345 105,945 94,051 5.1% 18.4% OPERATING INCOME 6,640 12,800 11,331 % % Interest expense 2,669 2,530 4,672 5.5% % Income from continuing operations before income tax expense 3,971 10,270 6,659 % % Income tax expense 2,962 2,053 3,663 44.3% % Income from continuing operations 1,009 8,217 2,996 % % Income from discontinued operations, net of income taxes — — — NM NM N..."
10/19/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement THIS EMPLOYMENT AGREEMENT is made by and between CORE LABORATORIES N.V. and Lawrence V. Bruno . W I T N E S S E T H: WHEREAS, Executive is currently an employee of Core Laboratories N.V. and/or one or more of its Affiliates ; and WHEREAS, Company desires to continue to employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive is desirous of continuing to be employed by Company on such terms and conditions, and for such consideration. NOW, THEREFORE, for and in consideration of the amounts and benefits to be paid and provided to Executive under this Agreement and the mutual promises, covenants, and undertakings contained herein, Company and Executive, each intending to be legally bound, hereby agree as follows: Article...",
"Employment Agreement THIS EMPLOYMENT AGREEMENT is made by and between CORE LABORATORIES N.V. and Christopher S. Hill . W I T N E S S E T H: WHEREAS, Executive is currently an employee of Core Laboratories N.V. and/or one or more of its Affiliates ; and WHEREAS, Company desires to continue to employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive is desirous of continuing to be employed by Company on such terms and conditions, and for such consideration. NOW, THEREFORE, for and in consideration of the amounts and benefits to be paid and provided to Executive under this Agreement and the mutual promises, covenants, and undertakings contained herein, Company and Executive, each intending to be legally bound, hereby agree as follows: Artic...",
"Employment Agreement THIS EMPLOYMENT AGREEMENT is made by and between CORE LABORATORIES N.V. and Gwendolyn Y. Schreffler . W I T N E S S E T H: WHEREAS, Executive is currently an employee of Core Laboratories N.V. and/or one or more of its Affiliates ; and WHEREAS, Company desires to continue to employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive is desirous of continuing to be employed by Company on such terms and conditions, and for such consideration. NOW, THEREFORE, for and in consideration of the amounts and benefits to be paid and provided to Executive under this Agreement and the mutual promises, covenants, and undertakings contained herein, Company and Executive, each intending to be legally bound, hereby agree as follows: A...",
"Employment Agreement THIS EMPLOYMENT AGREEMENT is made by and between CORE LABORATORIES N.V. and Mark D. Tattoli . W I T N E S S E T H: WHEREAS, Executive is currently an employee of Core Laboratories N.V. and/or one or more of its Affiliates ; and WHEREAS, Company desires to continue to employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive is desirous of continuing to be employed by Company on such terms and conditions, and for such consideration. NOW, THEREFORE, for and in consideration of the amounts and benefits to be paid and provided to Executive under this Agreement and the mutual promises, covenants, and undertakings contained herein, Company and Executive, each intending to be legally bound, hereby agree as follows: Article I..."
07/28/2021 8-K Quarterly results
Docs: "CORE LABORATORIES N.V. & SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended % Variance vs. Q1-21 vs. Q2-20 REVENUE $ 118,745 $ 108,383 $ 115,736 9.6% 2.6% OPERATING EXPENSES: Costs of services and sales 93,841 84,150 90,680 11.5% 3.5% General and administrative expense 9,670 8,461 9,221 14.3% 4.9% Depreciation and amortization 4,751 4,871 5,425 % % Inventory write-down — — 9,932 NM NM Other expense, net 3,045 NM NM Total operating expenses 105,945 96,761 118,303 9.5% % OPERATING INCOME 12,800 11,622 10.1% NM Interest expense 2,530 1,363 3,369 85.6% % Income from continuing operations before income tax expense 10,270 10,259 0.1% NM Income tax expense 2,053 2,052 —% NM Income from continuing operations 8,217 8,207 0.1% NM Income from discontinued operations, ne..."
05/19/2021 8-K Quarterly results
04/21/2021 8-K Quarterly results
01/27/2021 8-K Quarterly results
Docs: "CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS FROM CONTINUING"
01/15/2021 8-K Quarterly results
12/17/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Equity Distribution Agreement, by and between Core Laboratories N.V. and Wells Fargo Securities, LLC",
"Opinion of NautaDutilh N.V. regarding legality of the Common Shares",
"CORE LAB ANNOUNCES $60,000,000 AT-THE-MARKET EQUITY OFFERING PROGRAM"
10/21/2020 8-K Quarterly results
Docs: "CORE LAB REPORTS THIRD QUARTER 2020 RESULTS FROM CONTINUING"
10/16/2020 8-K Quarterly results
10/15/2020 8-K Quarterly results
07/22/2020 8-K Quarterly results
07/17/2020 8-K Quarterly results
06/23/2020 8-K Quarterly results
05/20/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/28/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CORE LAB ANNOUNCES Q2 2020 QUARTERLY DIVIDEND"
04/22/2020 8-K Quarterly results
Docs: "CORE LAB REPORTS FIRST QUARTER 2020 RESULTS FROM CONTINUING"
03/27/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CORE LAB RESCHEDULES TIME AND LOCATION OF ITS 2020 ANNUAL SHAREHOLDER MEETING WHILE MAINTAINING MEETING DATE OF MAY 20, 2020"
03/16/2020 8-K Quarterly results
03/05/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy